ArticleCancer chemotherapy and pharmacology2019

A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer.

Linda R Duska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.